Valeant Pharmaceuticals International (VRX)
Add to Watchlists Create an Alert
74.66
-0.16 -0.21%
NYSE
May 23, 4:59PM
BATS Real time
Currency in USD
Valeant Pharmaceuticals International Net Interest Income Quarterly:
-153.72M for March 31, 2013Valeant Pharmaceuticals International Historical Net Interest Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -153.72M |
| Dec. 31, 2012 | -152.03M |
| Sept. 30, 2012 | -114.89M |
| June 30, 2012 | -99.59M |
| March 31, 2012 | -100.90M |
| Dec. 31, 2011 | -92.57M |
| Sept. 30, 2011 | -86.45M |
| June 30, 2011 | -81.99M |
| March 31, 2011 | -67.95M |
| Dec. 31, 2010 | -52.56M |
| Sept. 30, 2010 | -11.09M |
| June 30, 2010 | -9.718M |
| March 31, 2010 | -9.639M |
| Dec. 31, 2009 | -9.736M |
| Sept. 30, 2009 | -10.76M |
| June 30, 2009 | -3.798M |
| March 31, 2009 | -0.006M |
| Dec. 31, 2008 | 0.443M |
| Sept. 30, 2008 | 1.537M |
| June 30, 2008 | 3.176M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Interest Income
Revenues from interest-bearing assets. A typical example would be interest earned by a bank on personal or commercial loans.
Learn More
VRX Net Interest Income Quarterly Benchmarks
| Companies | |
|---|---|
| Actavis | -53.70M |
| Mylan | -77.99M |
| Warner Chilcott | -65.00M |
VRX Net Interest Income Quarterly Rankings
| Overall |
38th percentile 4961 of 8006 |
| Sector |
14th percentile 587 of 686 in Healthcare |
| Industry |
8th percentile 62 of 68 in Drug Manufacturers - Specialty & Generic |
VRX Net Interest Income Quarterly Range, Past 5 Years
| Minimum | -153.72M | Mar 2013 |
| Maximum | 3.176M | Jun 2008 |
| Average | -52.61M |